(4S)-3-(FMoc-Thr(tBu))-2,2-diMethyl-oxazolidine-4-carboxylic acid
|
|
(4S)-3-(FMoc-Thr(tBu))-2,2-diMethyl-oxazolidine-4-carboxylic acid Eigenschaften
- Siedepunkt:
- 718.2±60.0 °C(Predicted)
- Dichte
- 1.223±0.06 g/cm3(Predicted)
- pka
- 3.03±0.40(Predicted)
Sicherheit
HS Code | 2934999090 |
---|
(4S)-3-(FMoc-Thr(tBu))-2,2-diMethyl-oxazolidine-4-carboxylic acid Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White to off-white powder(4S)-3-(FMoc-Thr(tBu))-2,2-diMethyl-oxazolidine-4-carboxylic acid Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
(4S)-3-(FMoc-Thr(tBu))-2,2-diMethyl-oxazolidine-4-carboxylic acid Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 53)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Alpha Biopharmaceuticals Co., Ltd | +86-15542445688 |
sales@alabiochem.com | China | 888 | 58 |
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 |
ivan@atkchemical.com | China | 32951 | 60 |
Shenzhen Nexconn Pharmatechs Ltd | +86-755-89396905 +86-15013857715 |
admin@nexconn.com | China | 10310 | 58 |
GL Biochem (Shanghai) Ltd. | +86-021-61263370 +86-18901917034 |
CHINA | 3904 | 58 | |
GL Biochem(Binhai) Ltd. | +86-021-61263370 +8615301650015 |
wuqiuyan@glschina.com | China | 2975 | 58 |
BOC Sciences | 16314854226; +16314854226 |
inquiry@bocsci.com | United States | 19741 | 58 |
Nextpeptide Inc | +86-0571-81612335 +8613336028439 |
sales@nextpeptide.com | China | 19908 | 58 |
VladaChem GmbH | +49-7246-3082843 |
info@vladachem.de | Germany | 1859 | 58 |
LEAPCHEM CO., LTD. | +86-852-30606658 |
market18@leapchem.com | China | 43340 | 58 |
Shanghai Leju Biotechnology Co., Ltd. | 021-56328558 13671549194 |
sales2@reliablebiochem.com | China | 300 | 58 |
- (4S)-3-(FMoc-Thr(tBu))-2,2-diMethyl-oxazolidine-4-carboxylic acid
- FMoc-Thr(tBu)-Ser(Psi(Me,Me)pro)-OH
- (4S)-3-[(2S,3R)-3-(1,1-Dimethylethoxy)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-oxobutyl]-2,2-dimethyl-4-oxazolidinecarboxylic acid
- (4S)-3-[N-(9-Fluorenylmethyloxycarbonyl-O-tert-butyl-L-threoninyl]-2,2-dimethyl-oxazolidine-4-carboxylic acid
- Fmoc-Thr(tBu)-Ser[Psi(Me,Me)Pro]-OH≥ 99% (HPLC)
- Fmoc-Thr(tBu)-Ser[Ψ(Me,Me)Pro]-OH
- (9H-Fluoren-9-yl)MethOxy]Carbonyl Thr(tBu)-SerPsi(Me, Me)Pro-OH
- (4S)-3-[(2S,3R)-3-(tert-butoxy)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid
- Fmoc-L-Thr(tBu)-L-Ser[psi(Me,Me)pro]-OH
- 4-Oxazolidinecarboxylic acid, 3-[(2S,3R)-3-(1,1-dimethylethoxy)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-oxobutyl]-2,2-dimethyl-, (4S)-
- (S)-3-(N-(((9H-fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyl)-L-threonyl)-2,2-dimethyloxazolidine-4-carboxylic acid
- (4S)-3-(FMoc-Thr(Otbu))-2,2-diMethyl-oxazolidine-4-carboxylic acid
- 1425938-63-1